The former is related to uncommon hereditary cases of AD (~5%), where patients have autosomal-dominant mutations in selected genes (e.g., APP, PSEN1, and PSEN2), resulting in increased production of Aβ [19]. This evidence concerns the gene APP and Alzheimer disease.